Thursday, September 13, 2018

Versant Ventures, MPM Capital Launch Gene Therapy Startup, CODA Biotherapeutics

San Diego-based biotech investor Versant Ventures, along with MPM Capital, said today that they have launched a new startup, CODA Biotherapeutics. The companies said they invested $19M in the Series A funding for CODA Biotherapeutics, along with Astellas Venture Management and Novartis. CODA says it is developing gene therapy techniques, around what it calls a "chemogenetic platform" which it says aims to control the activity of neurons and other cells to treat diseases. CODA Biotherapeutics is based in San Francisco. More information »